Atlas Trials

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Clinical trial NCT00657501 · COMPLETED

Trial details

NCT number
NCT00657501
Sponsor
BioSante Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypoactive Sexual Desire Disorder
Start date
2008-03-01
Primary completion
2011-09-01
Enrollment
575

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.